Print-friendly View
Resources for Health Professionals and Patients
| Review: Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomized controlled phase III trial | |||
Attached file: |
(Russian, 255.1 kb)
Review in Russian
| ||
Link to document(s) | http://www.ncbi.nlm.nih.gov... | ||
Author(s): | J. V. Madruga et. al | ||
Document type: | Literature Reviews | ||
Language: | English, Russian | ||
Original language of document: | Russian | ||
Publication date: | July 7, 2007 | ||
Primary area(s) of focus: | HIV/AIDS | ||
Secondary areas of focus: | Antiretroviral Therapy (ART), Clinical trials | ||
Submited by: | Victor Stanilevskiy | ||
Material written specifically for patients: | No | ||
Date of entry: | August 15, 2007 | ||
Pages: | 3 | ||
| This article review was prepared by the Internet project MedMir.com, which is aimed to provide Russian speaking medical professionals with timely, comprehensive and relevant clinical information in the form of the Russian language summaries of clinical study reports published in the top world medical journals. | |||
Overall user rating: | Not yet reviewed | ||
